As of November 2024, Medigen Vaccine Biologics Corporation has a market cap of $480.48M. This makes Medigen Vaccine Biologics Corporation the world's 11656th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $634.47M | -11.84% |
2023 | $719.69M | 0.86% |
2022 | $713.53M | -76.76% |
2021 | $3.07B | 190.29% |
2020 | $1.06B | 261.40% |
2019 | $292.60M | -17.88% |
2018 | $356.31M | 29.25% |
2017 | $275.68M | -10.79% |
2016 | $309.01M | -5.36% |
2015 | $326.51M | - |